Home » Topics » Disease categories and therapies » Infection

Infection
RSS

HMR prepares new antibacterial agents for Gram-positive infections

March 6, 1998

FDA approves expanded indications for Dynabac

March 6, 1998

New introduction for Glaxo Wellcome/Otsuka broad-spectrum fluoroquinolone

March 5, 1998

Liposomal ciprofloxacin formulations demonstrate high efficacy and versatility

March 4, 1998

Efficacy of immunoliposomal amphotericin B confirmed in mice with invasive aspergillosis

March 4, 1998

CFC-222 compared to other fluoroquinolones in vitro and in vivo

March 3, 1998

Lilly glycopeptide antibiotic compared to vancomycin and teicoplanin in vitro

March 2, 1998

Pharmacodynamics of HMR-3647 against respiratory pathogens, enterococci and B. fragilis

March 2, 1998

Novel antiviral agents from Lilly

March 2, 1998

Patent coverage for ProLease interferon

Feb. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Kymera’s IRF5 degrader shows potential in IBD treatment
BioWorld Science
At the recently concluded Digestive Disease Week, researchers from Kymera Therapeutics Inc. presented preclinical efficacy data on KT-579, a selective oral IRF5...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...